Insights

Funding & Financials Insitro has secured a total funding of $400 million, indicating strong financial backing and potential for significant sales opportunities.

Recent Expansions Insitro received $400M in Series D financing, showcasing growth and a need for expanded capabilities, creating potential sales avenues to support their expansion.

Key Personnel Amy Abernethy, a highly accomplished leader in the healthcare industry, joined Insitro's board of directors, presenting a prime opportunity for strategic partnerships and sales collaborations through her expertise.

Industry Recognition Insitro's innovative approach to drug discovery using machine learning has attracted significant investments from established players like SoftBank, indicating industry validation and potential partnership opportunities for sales growth.

Competitive Positioning In a market with companies of varying sizes and revenue ranges, Insitro's revenue of $50-100 million places them among reputable competitors like BenevolentAI, presenting sales opportunities to leverage their unique value proposition and technology.

insitro Tech Stack

insitro uses 8 technology products and services including Oracle Cloud, Saba, jQuery, and more. Explore insitro's tech stack below.

  • Oracle Cloud
    Data Management Platforms
  • Saba
    Human Resource Management System
  • jQuery
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • Glassdoor
    Online Review Management
  • Linux
    Programming Languages
  • Smartsheet
    Project Management
  • Bootstrap
    UI Frameworks

Media & News

insitro's Email Address Formats

insitro uses at least 1 format(s):
insitro Email FormatsExamplePercentage
first@insitro.comJohn@insitro.com
50%
flast@insitro.comJDoe@insitro.com
29%
first.last@insitro.comJohn.Doe@insitro.com
16%
last@insitro.comDoe@insitro.com
5%

Frequently Asked Questions

Where is insitro's headquarters located?

Minus sign iconPlus sign icon
insitro's main headquarters is located at 259 E Grand Ave South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is insitro's official website and social media links?

Minus sign iconPlus sign icon
insitro's official website is insitro.com and has social profiles on LinkedIn.

How much revenue does insitro generate?

Minus sign iconPlus sign icon
As of June 2024, insitro's annual revenue reached $75M.

What is insitro's SIC code NAICS code?

Minus sign iconPlus sign icon
insitro's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does insitro have currently?

Minus sign iconPlus sign icon
As of June 2024, insitro has approximately 310 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief People Officer: J. S. L.Chief People Officer: S. L.Chief People Officer: S. L.. Explore insitro's employee directory with LeadIQ.

What industry does insitro belong to?

Minus sign iconPlus sign icon
insitro operates in the Biotechnology Research industry.

What technology does insitro use?

Minus sign iconPlus sign icon
insitro's tech stack includes Oracle CloudSabajQueryTensorFlowGlassdoorLinuxSmartsheetBootstrap.

What is insitro's email format?

Minus sign iconPlus sign icon
insitro's email format typically follows the pattern of . Find more insitro email formats with LeadIQ.

How much funding has insitro raised to date?

Minus sign iconPlus sign icon
As of June 2024, insitro has raised $400M in funding. The last funding round occurred on Mar 15, 2021.

When was insitro founded?

Minus sign iconPlus sign icon
insitro was founded in 2018.
insitro

insitro

Biotechnology ResearchCalifornia, United States201-500 Employees

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach to drug development – one that leverages machine learning and unique in vitro strategies for modeling disease state and designing new therapeutic interventions. We aim to eliminate key bottlenecks in traditional drug discovery, so we can help more people sooner and at a much lower cost to the patient and the healthcare industry.
 
We believe that by harnessing the power of technology to interrogate and measure human biology, we can have a major impact on many diseases. We invest heavily in cutting edge bioengineering technologies to enable the construction of large-scale, high-quality data sets that are designed specifically to drive machine learning methods. Our first application is to use human genetics, functional genomics, and machine learning to build a new generation of in vitro human cell-derived disease models whose response to perturbation is designed to be predictive of human clinical outcomes. 
 
This cannot be done without great people. We are bringing together an outstanding team of people whose expertise spans multiple disciplines - life sciences, machine learning, human genetics, engineering, and drug discovery - and building a unique culture where people from diverse backgrounds work as a single team towards a common goal. We offer opportunities to collaborative people with expertise in life science and computational science. Join us to help bring better health to more people, faster and cheaper.

Section iconCompany Overview

Headquarters
259 E Grand Ave South San Francisco, California 94080 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
201-500

Section iconFunding & Financials

  • $400M

    insitro has raised a total of $400M of funding over 3 rounds. Their latest funding round was raised on Mar 15, 2021.

  • $50M$100M

    insitro's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $400M

    insitro has raised a total of $400M of funding over 3 rounds. Their latest funding round was raised on Mar 15, 2021.

  • $50M$100M

    insitro's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.